Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

ECS Botanics signs landmark medicinal cannabis resin supply deal with Cannvalate

EZZ Life Science moves into genomics and precision nutrition space

InhaleRx’s Medihale vape pods to have two new EC Pharma medicinal cannabis formulations

ECS Botanics inks cannabis supply and tolling deal with Sun Pharma

Prescient Therapeutics bolsters scientific advisory board with CAR-T and bioengineering experts

Amplia Therapeutics confirms anti-cancer drug AMP945 can inhibit focal adhesion kinase in healthy volunteers

Invion to raise $15m to fund ongoing Photosoft technology development and expand market reach

Montu raises funds to advance medical cannabis telehealth platform as revenue surges

Aegros’ HaemaFrac plasma fraction process offers new defence against COVID-19 and other diseases

Invex Therapeutics chases global registration of Presendin to treat idiopathic intracranial hypertension

Argenica Therapeutics reveals positive pre-clinical results of stroke drug ARG-007 in HIE

ECS Botanics raises $6.6m to accelerate growth after record September quarter

Greenlab awarded co-funding grant to help grow New Zealand’s medicinal cannabis industry

Study shows Invion’s INV043 could regress triple negative breast cancer tumours

Incannex Healthcare receives pre-IND guidance and ethics approval to begin phase 2a psychedelic trial

Amplia Therapeutics secures renowned oncology drug development expert as clinical advisor

Invion has productive quarter following $4.5m capital raise for next-gen photodynamic therapy to treat billion-dollar diseases

Invex Therapeutics reports busy quarter in Presendin development

Incannex Healthcare moves forward with soft gel capsule design for IHL-42X to treat obstructive sleep apnoea

Osteopore and Singular Health collaborate on AI-powered cranial implant design process

Argenica Therapeutics to start phase 1 clinical trials early next year